1. Stocks
    2. /
  2. Johnson & Johnson (NYSE: JNJ)
    3. /

Johnson & Johnson (NYSE: JNJ) Share Price and News

$244.62 $2.58 (1.1%) 14 March 2026 at 1:55:09 am AEDT

Johnson & Johnson Chart and Price Data

About Johnson & Johnson

Last updated 14-03-2026, 01:55:09am AEDT
Current Price $244.62
Change $2.58 (1.1%)
Close Price $242.04
Open Price $244.21
Bid $244.58
Ask $244.64
Day Range $242.40 - $245.59
Year Range $141.50 - $251.71
Volume 1,822,426
Average Volume 8,856,092
Market Cap $701,252,084,210.00
Earnings Per Share $11.05

Johnson & Johnson (NYSE: JNJ)
Latest News

US 100 dollar notes with a gavel on top of it
International Stock News

Supreme Court rules Johnson & Johnson must pay $2.1 billion in baby powder lawsuit

| Eric Volkman

The company has set aside nearly $4 billion as a "litigation expense."

Read more »

Platinum Asset Management's Dr Bianca Ogden
Ask a Fund Manager

This fundie has a PhD in healthcare: now she invests in it

| Tony Yoo

Ask A Fund Manager: Platinum Asset Management's Dr Bianca Ogden tells how she used to work for the company that's…

Read more »

Covid-19 vaccine
International Stock News

How Johnson & Johnson beat expectations in Q1

| Keith Speights

The healthcare giant saw a marked recovery from the negative impacts of the COVID-19 pandemic.

Read more »

A line of people sitting at a long desk in an annual general meeting
International Stock News

2 things investors need to look for in Johnson & Johnson's earnings tomorrow

| Alex Carchidi

Formally addressing the recent challenges will help to put shareholders at ease again.

Read more »

health worker holding a vaccine in their hand
International Stock News

The Johnson & Johnson COVID vaccine halt: here's what investors need to know

| Adria Cimino

Officials are investigating "severe" blood clots in some people.

Read more »

health worker wearing personal protective equipment and gesturing stop with her hands
International Stock News

U.S. gives Johnson & Johnson's COVID-19 vaccine a timeout

| Cory Renauer

Out of an abundance of caution, the FDA and CDC have recommended a pause in the use of the only…

Read more »

Five different pggy banks, indicating a diverse share portfolio
ETFs

2 top ASX ETFs to buy right now

| Sebastian Bowen

The iShares S&P 500 ETF (ASX: IVV) is one of two ASX ETFs to buy today for ASX share portfolio…

Read more »

coronavirus vaccine represented by gloved hand drawing down from syringe
International Stock News

Johnson & Johnson coronavirus vaccine wins FDA authorisation

| Eric Volkman

The big pharmaceutical company's jab has some important advantages.

Read more »

Cash piled up in the middle of a bear trap symbolising risky investments
International Stock News

Why Moderna Is Less Risky Than You Think

| Manali Bhade

Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

Read more »

doctor giving little boy vaccine injection in his arm
International Stock News

Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

| Brian Orelli, PhD

The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

Read more »

doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
International Stock News

The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

| Keith Speights

Hint: It's not Moderna.

Read more »

CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
International Stock News

Coronavirus vaccine race: 7 key things you'll want to know

| Keith Speights

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

Read more »

Profile

since

Note